Capital Advisors Inc Intellia Therapeutics, Inc. Transaction History

Capital Advisors Inc

$4.75 Billion
Q2 2024

A detailed history of Capital Advisors Inc transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Capital Advisors Inc holds 311,045 shares of NTLA stock, worth $5.6 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

311,045

Previous 300,653 3.46%

Holding current value

$5.6 Million

Previous $8.27 Million 15.83%

% of portfolio

0.15%

Previous 0.18%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	BUY	$20.02 - $27.22 $208,047 - $282,870	10,392 Added 3.46%	311,045 $6.96 Million
Q1 2024 Apr 29, 2024	BUY	$23.82 - $32.8 $379,095 - $522,011	15,915 Added 5.59%	300,653 $8.27 Million
Q4 2023 Jan 29, 2024	BUY	$23.16 - $32.34 $1.7 Million - $2.37 Million	73,379 Added 34.72%	284,738 $8.68 Million
Q3 2023 Oct 24, 2023	BUY	$31.62 - $45.78 $459,723 - $665,595	14,539 Added 7.39%	211,359 $6.68 Million
Q2 2023 Jul 18, 2023	BUY	$34.58 - $46.03 $291,855 - $388,493	8,440 Added 4.48%	196,820 $8.03 Million
Q1 2023 Apr 19, 2023	BUY	$33.3 - $44.82 $490,309 - $659,929	14,724 Added 8.48%	188,380 $7.02 Million
Q4 2022 Jan 17, 2023	BUY	$33.21 - $62.69 $59,844 - $112,967	1,802 Added 1.05%	173,656 $0
Q3 2022 Oct 17, 2022	BUY	$53.92 - $71.7 $244,149 - $324,657	4,528 Added 2.71%	171,854 $9.62 Million
Q2 2022 Jul 15, 2022	BUY	$38.49 - $76.21 $3.17 Million - $6.28 Million	82,405 Added 97.04%	167,326 $8.66 Million
Q1 2022 May 05, 2022	BUY	$58.27 - $118.99 $313,376 - $639,928	5,378 Added 6.76%	84,921 $6.17 Million
Q4 2021 Jan 27, 2022	BUY	$100.76 - $138.36 $3.56 Million - $4.88 Million	35,298 Added 79.78%	79,543 $9.41 Million
Q3 2021 Oct 25, 2021	BUY	$132.37 - $176.78 $5.58 Million - $7.45 Million	42,145 Added 2006.9%	44,245 $5.94 Million
Q2 2021 Aug 02, 2021	BUY	$60.88 - $161.91 $127,848 - $340,011	2,100 New	2,100 $340,000
Q4 2018 Feb 06, 2019	SELL	$11.39 - $27.13 $1.26 Million - $2.99 Million	-110,239 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$25.78 - $32.6 $59,990 - $75,860	2,327 Added 2.16%	110,239 $3.16 Million
Q2 2018 Aug 06, 2018	SELL	$20.02 - $30.79 $10,270 - $15,795	-513 Reduced 0.47%	107,912 $0
Q1 2018 May 04, 2018	BUY	$19.43 - $34.95 $139,798 - $251,465	7,195 Added 7.11%	108,425 $0
Q4 2017 Jan 29, 2018	BUY	$17.39 - $31.12 $1.76 Million - $3.15 Million	101,230	101,230 $1.95 Million

Others Institutions Holding NTLA

# of Institutions

326

Shares Held

88.8M

Call Options Held

673K

Put Options Held

865K

View Full List

About Intellia Therapeutics, Inc.

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $1.37B
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

More about NTLA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Capital Advisors Inc with notifications on news.

Account

Capital Advisors Inc Intellia Therapeutics, Inc. Transaction History